Parenteral Nutrition Fundamentals: Indications, Macronutrient Compounding, Electrolytes, and Refeeding Risk
Executive Summary
Parenteral nutrition (PN) is indicated when the gut cannot meet caloric needs for ≥7 days. Targets are typically 25-30 kcal/kg/day and 1.2-2.0 g protein/kg/day, balanced as 50-60% dextrose, 20-30% lipid, and 15-20% amino acids. The most preventable disaster is refeeding syndrome — give thiamine 200-300 mg IV first, start at 5-10 kcal/kg/day in high-risk patients, and replete phosphate/potassium/magnesium daily. Long-term PN demands central venous access (PICC, tunneled, port), strict aseptic technique, lipid rotation to prevent IFALD, and cycling to limit hepatic steatosis.
S1. Indications and Risk Stratification
Parenteral nutrition delivers macro- and micronutrients directly into the systemic circulation, bypassing the GI tract. It is reserved for patients who cannot meet at least 60% of caloric needs by enteral or oral routes for an anticipated duration of 7 or more days. The decision is never trivial: PN doubles infectious complications and adds metabolic risk compared with enteral nutrition, so the gut should always be used when at all possible — even small trickle feeds preserve gut barrier integrity, IgA secretion, and bile acid recirculation.
EN-vs-PN decision framework
Absolute indications for PN include short bowel syndrome (residual jejunum <100 cm without colon, <60 cm with colon), high-output enterocutaneous fistula (>500 mL/day) where downstream feeding is impossible, severe intestinal pseudo-obstruction (CIPO), mesenteric ischemia awaiting revascularization, and chemotherapy-induced mucositis with grade 3-4 oral intake failure. Relative indications include severe acute pancreatitis intolerant of jejunal feeds (a small minority), prolonged ileus >7 days, and high-risk perioperative malnutrition before major GI/oncologic surgery (start PN 7-10 days preoperatively if NRS-2002 ≥5).
| Scenario | Recommendation | Notes |
|---|---|---|
| Functional gut, oral intake <60% × 5-7 d | Oral supplements, then EN | PN not indicated |
| NPO <7 d, well-nourished | IV maintenance fluids | Brief starvation tolerated |
| Anticipated NPO ≥7 d, well-nourished | PN day 7 if EN still impossible | EPaNIC supports late initiation |
| NRS-2002 ≥5 or NUTRIC ≥5, NPO | PN within 3-5 days | High nutritional risk |
| Short bowel, high fistula, CIPO | PN immediately | Often long-term/home PN |
| Severe pancreatitis intolerant of jejunal feeds | PN after 5-7 d EN failure | Most tolerate jejunal EN |
Timing in critically ill patients
The landmark EPaNIC trial (NEJM 2011) randomized 4640 ICU patients to early supplemental PN within 48 hours versus delayed PN starting on day 8 if EN remained inadequate. Late initiation reduced ICU stay by 1 day, decreased new infections (22.8% vs 26.2%), shortened ventilator time, and accelerated organ failure recovery A. The takeaway: in well-nourished ICU patients, do not rush PN — give EN every chance to work, accept hypocaloric feeding for the first week, and start PN on day 7-8 only if needed.
For high-risk malnourished patients (BMI <18.5, >10% weight loss, NRS-2002 ≥5), the calculus changes. ASPEN/SCCM guidelines recommend initiating PN as soon as feasible (within 3-5 days) when EN is contraindicated. The risk of further nutritional deterioration outweighs PN's complication burden in this group.
S2. Macronutrient Targets
PN macronutrient prescription begins with total energy and protein targets, then divides remaining calories between dextrose and lipid in a 60:40 to 70:30 ratio (non-protein calories). Indirect calorimetry is the gold standard but rarely available — most institutions use weight-based predictive equations.
Protein (amino acids)
Protein needs are dictated by metabolic stress and renal function. Healthy maintenance is 0.8 g/kg/day; mild illness 1.0-1.2 g/kg/day; ICU patients 1.2-2.0 g/kg/day; burn patients and CRRT recipients 2.0-2.5 g/kg/day. Use ideal body weight in obesity (BMI >30) targeting 2.0-2.5 g/kg ideal weight. Standard adult amino acid solutions are 8.5-15% (e.g., Aminosyn 10%, Travasol 10%, Clinisol 15%); branched-chain enriched (HepatAmine, Aminosyn-HBC) is reserved for refractory hepatic encephalopathy and offers no survival benefit in routine cirrhosis.
Protein delivery is independent of total calories — when calories are restricted (e.g., obese ICU patient on hypocaloric feeding), protein is preserved at ≥2.0 g/kg ideal weight. This "permissive underfeeding" preserves lean mass without overfeeding.
Carbohydrate and lipid
Dextrose monohydrate provides 3.4 kcal/g (not 4.0 — the monohydrate water adds mass without calories). Concentrations range from 5% to 70%; central-line PN typically uses 40-70% stock. Maximum infusion rate is 5 mg/kg/min in stable adults, but stress hyperglycemia often forces lower rates (3-4 mg/kg/min). Exceeding the maximum drives hepatic steatosis, hyperglycemia, hypercapnia (excess CO₂ from glycolysis), and infection risk.
Lipid emulsions provide essential fatty acids (linoleic, alpha-linolenic) and dense calories (9 kcal/g triglyceride; 1.1 kcal/mL of 10%, 2.0 kcal/mL of 20%, 3.0 kcal/mL of 30%). Five formulations exist: Intralipid (100% soybean, omega-6 heavy, pro-inflammatory), ClinOleic (80% olive/20% soybean, lower omega-6), Lipoplus (50% MCT/50% soybean, faster clearance), SMOFlipid (30% soybean/30% MCT/25% olive/15% fish, balanced), and Omegaven (100% fish oil, salvage for IFALD). For long-term PN, SMOFlipid is preferred because it lowers ALT/bilirubin and reduces IFALD progression versus pure soybean B.
| Lipid emulsion | Composition | Best use | Caveats |
|---|---|---|---|
| Intralipid 20% | 100% soybean (60% LA, 8% ALA) | Short-term PN, EFA repletion | Pro-inflammatory; IFALD risk long-term |
| ClinOleic 20% | 80% olive / 20% soybean | Long-term, lower omega-6 | Limited US availability |
| Lipoplus 20% | 50% MCT / 50% LCT soybean | Hypertriglyceridemia, faster clearance | Less EFA per gram |
| SMOFlipid 20% | 30% soybean/30% MCT/25% olive/15% fish | Long-term PN, IFALD prevention | Higher cost; FDA-approved adults & peds |
| Omegaven 10% | 100% fish oil (EPA, DHA) | Salvage for established IFALD | Insufficient EFA alone; combine if long term |
S3. Electrolytes, Vitamins, Trace Elements
Electrolyte requirements are highly individual and reflect baseline labs, renal function, GI losses, and refeeding risk. Standard adult daily provisions in PN are sodium 60-150 mEq, potassium 60-100 mEq, calcium 5-15 mEq, magnesium 8-20 mEq, and phosphate 20-40 mmol. Bicarbonate is not added directly — acetate is the buffer (1 mEq acetate yields 1 mEq HCO₃⁻ when metabolized).
| Electrolyte | Standard daily PN dose | Refeeding/depleted patient | Common limit |
|---|---|---|---|
| Sodium | 60-150 mEq | Per fluid status | Restrict in HF/cirrhosis |
| Potassium | 60-100 mEq | +20-40 mEq/day | ≤10 mEq/L peripheral; central up to 80 mEq/L |
| Calcium | 5-15 mEq (gluconate) | Per ionized Ca | Ca×Phos product <72 to avoid precipitation |
| Magnesium | 8-20 mEq (sulfate) | 16-32 mEq | Reduce in renal failure |
| Phosphate | 20-40 mmol | 40-60 mmol | Use Na or K phosphate per K balance |
| Acetate | 50-150 mEq | Per acid-base | Adjust Cl:acetate ratio |
| Chloride | Balance to charge | — | Avoid excess in hyperchloremic acidosis |
Multivitamins and trace elements
A single dose of adult multivitamin (MVI-12 or MVI Adult) added daily provides A, D, E, K (200 mcg in newer formulations), B-complex, folate, biotin, and ascorbate. Thiamine 200-300 mg IV is given separately before initiating PN in any high-risk refeeding patient — multivitamin provides only 6 mg, insufficient to prevent Wernicke-Korsakoff if reserves are depleted. Trace element solutions provide zinc 3-5 mg, copper 0.5-1.5 mg, manganese 60-100 mcg, chromium 10-15 mcg, and selenium 60-100 mcg. Iron is NOT in standard PN trace elements (incompatible with lipid; give as iron sucrose or ferric gluconate separately).
S4. Compounding Worked Example
A 70 kg ICU patient with anticipated NPO >7 days, no organ failure, BMI 24, NRS-2002 = 5. Total energy target 25 kcal/kg = 1750 kcal/day. Protein target 1.5 g/kg = 105 g/day = 420 protein calories.
Non-protein calories = 1750 − 420 = 1330 kcal. Distribute 60% as dextrose (798 kcal) and 40% as lipid (532 kcal):
- Dextrose: 798 ÷ 3.4 kcal/g = 235 g. Use 70% dextrose stock = 235 ÷ 0.7 = 336 mL of D70%. Glucose infusion rate = 235 g ÷ 70 kg ÷ 1440 min × 1000 = 2.3 mg/kg/min ✓ (well below 5 mg/kg/min ceiling).
- Lipid: 532 ÷ 2.0 kcal/mL = 266 mL of 20% SMOFlipid (provides 53 g lipid = 0.76 g/kg). Below 2.5 g/kg/day max ✓.
- Amino acids: 105 g protein. Use 15% Clinisol = 105 ÷ 0.15 = 700 mL.
Total volume = 336 (dextrose) + 266 (lipid) + 700 (AA) + ~200 mL electrolytes/additives = ~1500 mL. If patient needs additional fluid, supplement with maintenance crystalloid through a separate lumen.
Daily additives: NaCl 80 mEq + Na acetate 40 mEq, KCl 60 mEq + K phosphate 20 mmol (= 30 mEq K), Ca gluconate 10 mEq, MgSO₄ 12 mEq, MVI 1 vial, trace elements 1 vial. Insulin 0.05-0.1 unit per gram dextrose (start 0.05) added to bag if BG >180 mg/dL.
| Component | Amount | Calories | Provides |
|---|---|---|---|
| D70% dextrose | 336 mL | 798 kcal | 235 g carbohydrate |
| SMOFlipid 20% | 266 mL | 532 kcal | 53 g lipid + EFAs |
| Clinisol 15% AA | 700 mL | 420 kcal | 105 g protein |
| Total non-additive volume | 1302 mL | 1750 kcal | 25 kcal/kg, 1.5 g protein/kg |
Adjustments for renal failure (CRRT)
CRRT removes 6-15 g amino acids/day and water-soluble vitamins. Protein target rises to 2.0-2.5 g/kg/day. Phosphate replacement is critical — CRRT extracts ~7 mmol/L of phosphate, leading to hypophosphatemia within 48 hours. Add 30-50 mmol phosphate per day to the bag, or use phosphate-containing replacement fluid (e.g., Phoxilium).
S5. Monitoring and Refeeding Prevention
Refeeding syndrome
Refeeding syndrome is the single most preventable cause of PN-related death. After prolonged starvation, intracellular cations (phosphate, potassium, magnesium) are depleted; carbohydrate refeeding spikes insulin, driving these cations into cells, while thiamine reserves rapidly exhaust as glucose enters glycolysis. Severe hypophosphatemia (<1.0 mg/dL) precipitates respiratory muscle failure, cardiac dysfunction, hemolysis, and rhabdomyolysis. Wernicke encephalopathy from acute thiamine deficiency adds confusion, ataxia, and ophthalmoplegia.
NICE 2006 high-risk criteria (any one of the following): BMI <16, weight loss >15% in 3-6 months, no nutrition for >10 days, low pre-feed K/Mg/PO₄. Or two of: BMI <18.5, weight loss >10%, no nutrition >5 days, history of alcohol abuse / chemo / antacids / diuretics.
| Day | Energy target | Action |
|---|---|---|
| Pre-feeding | — | Thiamine , replete K/Mg/PO₄ to normal range, MVI 1 vial IV |
| Day 1-3 | 5-10 kcal/kg/day | Continue daily K/Mg/PO₄ checks; replete aggressively |
| Day 4-5 | 15 kcal/kg/day | Lab checks BID if electrolytes shifting |
| Day 6-7 | 20 kcal/kg/day | Daily labs |
| Day 8+ | 25-30 kcal/kg/day | Reach goal; transition labs to twice weekly |
Hyperglycemia management
Target blood glucose 140-180 mg/dL on PN (ICU and ward both). Add insulin to the PN bag at 0.05-0.1 unit per gram dextrose (start 0.05) if BG >180. Persistent hyperglycemia despite 0.2 unit/g warrants separate insulin drip with hourly checks. Sudden cessation of PN risks hypoglycemia from circulating insulin — taper over 1-2 hours by halving the infusion rate, or hang D10W at the prior PN rate for 1 hour.
Practice Insights: Refeeding Is the Biggest Mortal Risk, Not the PN Formula Itself
NICE Refeeding Risk Criteria Anchor the Start
in experienced hands, the most consequential first decision is identifying refeeding risk before starting PN. NICE criteria: high risk if any one of (1) BMI <16; (2) unintentional weight loss >15% in 3-6 months; (3) little or no nutritional intake for >10 days; (4) low pre-feeding K+, Mg++, PO4. Moderate risk if any two of (1) BMI 16-18.5; (2) weight loss 10-15%; (3) little intake >5 days; (4) alcohol use, chemotherapy, insulin/diuretic use. For any moderate or high risk patient, start PN at 50% of goal calories on day 1, advance over 5-7 days, give thiamine 200-300 mg IV before/with first dose, replace K+/Mg++/PO4 to high-normal range before starting calories, and monitor electrolytes 1-2x daily through first week.
Thiamine Before Glucose — Always
The single most underappreciated prerefeed step is thiamine repletion. Glucose-driven entry into the cell increases thiamine demand sharply; refeeding glucose into a thiamine-deficient malnourished patient precipitates Wernicke encephalopathy (confusion, ataxia, ophthalmoplegia) and lactic acidosis from blocked pyruvate dehydrogenase. The standard: thiamine 200-300 mg IV given at least 30 minutes before the first PN dose, continued daily for 5-7 days, then daily oral or IV supplementation. The dose is higher than the "100 mg" recommendation from decades past — the modern teaching is to push thiamine generously in any patient at refeeding risk because the downside of excess is negligible and the downside of insufficient is catastrophic.
SMOF Lipid Over Pure Soybean
For lipid emulsion choice, the established preference has shifted to SMOF (soybean + MCT + olive + fish oil mixture) over pure soybean (Intralipid) emulsions. SMOF has lower omega-6:omega-3 ratio, less inflammatory profile, better liver outcomes (lower incidence of PN-associated cholestasis especially in long-term users and infants), and clearer evidence in randomized trials over the past 5-10 years. Pure soybean remains acceptable for short-term use and is still available; for any patient expected to be on PN beyond 2 weeks, SMOF is the default. Lipid dose 1.0-1.5 g/kg/day for stable patients, lower (0.5-1.0 g/kg/day) for hypertriglyceridemia, omit entirely in egg/soy/peanut allergy.
The PN Line Is Sterile Territory
CRBSI prevention is the single biggest infectious morbidity reduction experienced clinicians can build into the workflow, and it rests on three rules: (1) dedicated PN lumen only — the PN port is not used for blood draws, antibiotic administration, or any non-PN purpose; this single rule reduces CRBSI by 40-60%; (2) maximum barrier precautions at insertion + CHG dressing; (3) aseptic hub disinfection 15 seconds with CHG/alcohol scrub before every access. PN through a peripheral line is limited to short-term (under 7-10 days) and lower osmolarity formulas (under 900 mOsm/L); central access is required for prolonged or higher-concentration PN. Tunneled catheters or PICCs for outpatient PN; ports for the most stable long-term home patients.
Illustrative Scenario
A patient in their forties with severe alcohol use disorder and 22 kg weight loss over 4 months was admitted with pancreatitis, BMI 16.2, K+ 3.0, Mg 1.4, PO4 1.8, baseline lactate 1.2. The admitting team initiated PN at full calorie goal (25 kcal/kg) on hospital day 2 without electrolyte prerepletion. On day 3 the patient developed worsening confusion, hyperventilation, hypophosphatemia (PO4 0.9), hypokalemia (K+ 2.4), and lactic acidosis (lactate 5.8) — refeeding syndrome was recognized. PN was held, thiamine 500 mg IV was given, aggressive electrolyte repletion (KCl, MgSO4, sodium and potassium phosphate replacement IV), and PN was restarted at 25% calorie goal with thiamine cover and twice-daily electrolyte monitoring. Patient recovered over 5 days with PN advancement to full goal over 10 days, and was transitioned to enteral feeds and discharged at hospital day 21.
Practice Pattern Refinements vs Standard Algorithm
- NICE refeeding risk screening before initiating PN. BMI, weight loss %, days of intake, baseline electrolytes. High-risk patients start at 25-50% calorie goal with thiamine pre-treatment and electrolytes prerepleted to high-normal range.
- Thiamine 200-300 mg IV before first PN dose, continued daily 5-7 days. The "100 mg" recommendation is outdated. Higher doses are safer and prevent Wernicke encephalopathy and lactic acidosis in glucose-stressed thiamine-deficient patients.
- SMOF lipid emulsion preferred for PN beyond 2 weeks. Lower omega-6:omega-3 ratio, less inflammatory, better liver outcomes than pure soybean for prolonged use. Pure soybean acceptable for short-term only.
- Dedicated PN lumen — no blood draws, no other access. Single highest-impact CRBSI prevention. Combined with maximum barriers, CHG dressing, and 15-second hub scrub before every access, reduces CRBSI by 40-60%.
S6. Complications, Pearls, and FAQs
| Complication | Incidence | Prevention/Management |
|---|---|---|
| CLABSI | 0.5-2 per 1000 catheter-days | Aseptic insertion bundle, chlorhexidine dressings, dedicated PN lumen, ethanol locks for home PN |
| Catheter occlusion | 10-30% long-term | Saline flushes; alteplase 2 mg dwell × 30-120 min for fibrin sheaths |
| Catheter thrombosis | 5-20% upper extremity | Tip placement at SVC-RA junction; DOAC or LMWH if recurrent |
| IFALD | 40-60% long-term soybean | SMOFlipid, cycle PN 12-16h, oral/EN as soon as possible, ursodiol 10-15 mg/kg/day |
| Hyperglycemia | 30-50% | Insulin in bag, target 140-180 mg/dL |
| Hypertriglyceridemia (>400) | 10-25% | Hold lipid until <400; switch to MCT-containing or fish-oil emulsion |
| Refeeding syndrome | Up to 48% high-risk | Slow start, thiamine, daily electrolyte repletion |
| Metabolic bone disease | 40-70% long-term PN | DEXA annually, calcium/vit D, bisphosphonates if osteoporosis |
| Aluminum toxicity | Rare; pediatric/renal | FDA limit 5 mcg/kg/day; check Al levels in long-term renal failure |
Clinical Pearl
Always give thiamine 200-300 mg IV before the first PN bag in any patient who has had inadequate intake for ≥5 days, has alcohol use disorder, or is on chronic diuretics. Multivitamin alone is insufficient. The cost is trivial; the protection against fatal Wernicke encephalopathy is enormous. Document this in your initial PN order set as a hard stop.
Common Pitfall
Stopping PN abruptly in a patient on insulin causes profound hypoglycemia within 30 minutes — circulating insulin keeps acting after the dextrose source vanishes. Always either taper PN over 1-2 hours by halving the rate, or hang D10W at the same volume rate for 1 hour after PN ends. This is a frequent cause of hypoglycemia codes on the surgical wards.
Clinical Pearl
For patients on PN >7 days, switch from continuous to cyclic infusion (12-16 hours overnight, off during the day). This mimics physiologic feeding patterns, allows daytime mobility, reduces hepatic steatosis, and improves quality of life. Begin by compressing infusion to 20 hours, then 16, then 12 — monitoring glucose tolerance at each step.
Common Pitfall
Underestimating protein needs in obesity and CRRT. A 120 kg patient with BMI 38 on CRRT needs ~150 g protein/day (2.0-2.5 g/kg ideal weight) — not 96 g (0.8 g/kg actual weight). Underdosing accelerates lean mass loss and impairs wound healing. Use ideal body weight or adjusted body weight for protein calculations in obesity, never actual.
Frequently Asked Questions
For previously well-nourished ICU patients, initiate PN after 7 days if enteral nutrition is not feasible or tolerated. For high-risk malnourished patients (NRS-2002 ≥5 or NUTRIC ≥5), initiate PN within 3-5 days when EN is contraindicated. Avoid early supplemental PN within the first week as the EPaNIC trial showed harm.
Refeeding syndrome is intracellular electrolyte shifts (phosphate, potassium, magnesium) and thiamine depletion when nutrition is reintroduced after starvation. Prevention: identify high-risk patients (BMI <16, weight loss >15%, intake <10 days), give thiamine 200-300 mg IV before feeding, start at 5-10 kcal/kg/day, advance over 5-7 days, replete phosphate/potassium/magnesium aggressively, and monitor electrolytes daily for the first week.
Hold or reduce lipids if triglycerides exceed 400 mg/dL. SMOFlipid (mixed soybean/MCT/olive/fish) and Omegaven (pure fish oil) are preferred over pure soybean (Intralipid) for long-term PN to reduce intestinal failure-associated liver disease (IFALD). Maximum lipid dose is 2.5 g/kg/day; provide at minimum 100 g/week to prevent essential fatty acid deficiency.
Catheter-related bloodstream infection (CLABSI, 0.5-2 per 1000 catheter-days), catheter occlusion or thrombosis, intestinal failure-associated liver disease (IFALD, 40-60% with long-term soybean lipid), metabolic bone disease, micronutrient deficiencies (manganese, copper, selenium), and hyperglycemia. Cycling PN over 12-16 hours rather than continuous infusion reduces hepatic steatosis.
Total energy 25 kcal/kg = 1750 kcal. Protein 1.5 g/kg = 105 g (420 kcal, 24%). Lipid 1 g/kg = 70 g (630 kcal, 36%, 350 mL of 20% lipid). Dextrose remaining 700 kcal / 3.4 kcal/g = 206 g (515 mL of 40% dextrose). Final volume ~2 L with sodium 80-100 mEq, potassium 60-80 mEq, calcium 10 mEq, magnesium 8-12 mEq, phosphate 20-40 mmol, plus standard multivitamins and trace elements.
- Enteral Nutrition Fundamentals: Tube Feeding, Formula Selection, and Complication Management
- Esophagogastroduodenoscopy: Indications, Technique, and Findings
- Obesity Pharmacotherapy: Tirzepatide, Semaglutide, Phentermine-Topiramate
- Acute Pancreatitis Admission Order Set: Resuscitation, Pain Control, and Nutrition
- NAFLD and MASLD: Diagnosis, Risk Stratification, and Management
- IgA Nephropathy: Diagnosis, Risk Stratification, and Treatment
Primary guideline documents this article draws on. Links resolve via DOI to the publisher; access may require a subscription.